MAXIMUS MMS Form 4: 2,565 RSUs to principal accounting officer

Rhea-AI Filing Summary

MAXIMUS, Inc. (MMS) reported an equity award to a senior executive. Principal Accounting Officer Theresa D. Golinvaux received a grant of 2,565 restricted stock units (RSUs) of common stock on 11/24/2025 at a price of $0 per share. These RSUs are scheduled to vest in four equal annual installments on 09/30/2026, 09/30/2027, 09/30/2028, and 09/30/2029, with the possibility of deferred vesting at her election under the award terms. After this grant, she beneficially owns 12,814.213 shares of MAXIMUS common stock in total.

Insider Trade Summary

Net Buyer: 2,565 shares

Net Buy 1 txn

Insider GOLINVAUX THERESA D

Role Principal Accounting Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	2,565	$0.00	$0.00

Holdings After Transaction: Common Stock — 12,814.213 shares (Direct)

Footnotes (1)

1. F1. Represents a grant of restricted stock units ("RSUs"), which vest based upon the following schedule, subject to deferred vesting for a longer period of the election of the individual, as permitted by the terms of the award: A 4-year ratable vest that occurs on 09/30/2026, 09/30/2027, 09/30/2028, and 09/30/2029. Each RSU represents a contingent right to receive one share of common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 11/25/2025 - 04:50 PM Learn about SEC filing dates

FAQ

What did MAXIMUS (MMS) report in this Form 4 filing?

The filing reports that Principal Accounting Officer Theresa D. Golinvaux received a grant of 2,565 restricted stock units (RSUs) of MAXIMUS common stock.

When were the 2,565 RSUs for MAXIMUS (MMS) granted?

The 2,565 RSUs were granted on 11/24/2025, as shown in Table I of the filing.

What is the vesting schedule for the MAXIMUS (MMS) RSU grant?

The RSUs vest in four equal annual installments on 09/30/2026, 09/30/2027, 09/30/2028, and 09/30/2029, with the option for deferred vesting under the award terms.

How many MAXIMUS (MMS) shares does the reporting person own after the RSU grant?

Following the reported transaction, Theresa D. Golinvaux beneficially owns 12,814.213 shares of MAXIMUS common stock.

What does each RSU represent in the MAXIMUS (MMS) Form 4?

Each RSU represents a contingent right to receive one share of MAXIMUS common stock upon vesting.

Was there any cash consideration for the MAXIMUS (MMS) RSU grant?

The Form 4 lists the transaction price as $0, indicating this was an equity compensation grant rather than an open-market purchase.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GOLINVAUX THERESA D

(Last) (First) (Middle)

C/O MAXIMUS INC.

1600 TYSONS BLVD, STE 1400

(Street)

MCLEAN VA 22102

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MAXIMUS, INC. [ MMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Principal Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
11/24/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/24/2025		A		2,565(1)	A	$0	12,814.213	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of restricted stock units ("RSUs"), which vest based upon the following schedule, subject to deferred vesting for a longer period of the election of the individual, as permitted by the terms of the award: A 4-year ratable vest that occurs on 09/30/2026, 09/30/2027, 09/30/2028, and 09/30/2029. Each RSU represents a contingent right to receive one share of common stock.

	/s/ John T Martinez: As Attorney-In-Fact for: Theresa D Golinvaux	11/25/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.